These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9175803)

  • 1. Pretransplant famciclovir as prophylaxis for hepatitis B virus recurrence after liver transplantation.
    Singh N; Gayowski T; Wannstedt CF; Wagener MM; Marino IR
    Transplantation; 1997 May; 63(10):1415-9. PubMed ID: 9175803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Famciclovir treatment of hepatitis B infection following liver transplantation: a long-term, multi-centre study.
    Manns MP; Neuhaus P; Atkinson GF; Griffin KE; Barnass S; Vollmar J; Yeang Y; Young CL;
    Transpl Infect Dis; 2001 Mar; 3(1):16-23. PubMed ID: 11429035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation.
    Seehofer D; Rayes N; Naumann U; Neuhaus R; Müller AR; Tullius SG; Berg T; Steinmüller T; Bechstein WO; Neuhaus P
    Transplantation; 2001 Oct; 72(8):1381-5. PubMed ID: 11685107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study.
    Krüger M; Tillmann HL; Trautwein C; Bode U; Oldhafer K; Maschek H; Böker KH; Broelsch CE; Pichlmayr R; Manns MP
    Liver Transpl Surg; 1996 Jul; 2(4):253-62. PubMed ID: 9346658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation.
    Rayes N; Seehofer D; Hopf U; Neuhaus R; Naumann U; Bechstein WO; Neuhaus P
    Transplantation; 2001 Jan; 71(1):96-101. PubMed ID: 11211203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hepatitis B-related polyarteritis nodosa with famciclovir and interferon alfa-2b.
    Kruger M; Böker KH; Zeidler H; Manns MP
    J Hepatol; 1997 Apr; 26(4):935-9. PubMed ID: 9126810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disappearance of hepatitis B virus core deletion mutants and successful combined kidney/liver transplantation in a patient treated with lamivudine.
    Meisel H; Preikschat P; Reinke P; Hocher B; Budde K; Bechstein WO; Neuhaus P; Krüger DH; Neumayer HH
    Transpl Int; 1999; 12(4):283-7. PubMed ID: 10460876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss.
    de Man RA; Bartholomeusz AI; Niesters HG; Zondervan PE; Locarnini SA
    J Hepatol; 1998 Oct; 29(4):669-75. PubMed ID: 9824278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of recurrent hepatitis B infection after liver transplantation. A retrospective analysis of 200 liver transplantations based on hepatitis B associated liver diseases].
    Seehofer D; Rayes N; Bechstein WO; Naumann U; Neuhaus R; Berg T; Hopf U; Langrehr JM; Steinmüller T; Platz KP; Müller AR; Neuhaus P
    Z Gastroenterol; 2000 Sep; 38(9):773-83. PubMed ID: 11072673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.
    Tchervenkov JI; Tector AJ; Barkun JS; Sherker A; Forbes CD; Elias N; Cantarovich M; Cleland P; Metrakos P; Meakins JL
    Ann Surg; 1997 Sep; 226(3):356-65; discussion 365-8. PubMed ID: 9339942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation.
    Lau GK; Liang R; Wu PC; Lee CK; Lim WL; Au WY
    J Hepatol; 1998 Mar; 28(3):359-68. PubMed ID: 9551671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels.
    Wiegand J; Wedemeyer H; Finger A; Heidrich B; Rosenau J; Michel G; Bock CT; Manns MP; Tillmann HL
    Antivir Ther; 2008; 13(4):547-54. PubMed ID: 18672533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Famciclovir treatment in transplant recipients with HBV-related liver disease: disappointing results.
    Berenguer M; Prieto M; Rayón M; Bustamante M; Carrasco D; Moya A; Pastor MA; Gobernado M; Mir J; Berenguer J
    Am J Gastroenterol; 2001 Feb; 96(2):526-33. PubMed ID: 11232701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of famciclovir for recurrent or de novo hepatitis B virus infection after liver transplantation.
    Rayes N; Seehofer D; Bechstein WO; Müller AR; Berg T; Neuhaus R; Neuhaus P
    Clin Transplant; 1999 Dec; 13(6):447-52. PubMed ID: 10617232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete hepatitis B virus prophylaxis withdrawal in hepatitis B surface antigen-positive liver transplant recipients after longterm minimal immunosuppression.
    Lenci I; Baiocchi L; Tariciotti L; Di Paolo D; Milana M; Santopaolo F; Manzia TM; Toti L; Svicher V; Tisone G; Perno CF; Angelico M
    Liver Transpl; 2016 Sep; 22(9):1205-13. PubMed ID: 27272189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical investigation of famciclovir in chronic hepatitis B patients irresponsive to alpha interferon treatment].
    Wang ZY; Guo SH; Zhang DF; Zhao YR; Ren H; Zhou XQ; Xu DZ; Sun JY; Yao JL; Lu WL
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):494-6. PubMed ID: 16042882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Famciclovir therapy for recurrent hepatitis B virus infection after liver transplantation.
    Haller GW; Bechstein WO; Neuhaus R; Raakow R; Berg T; Hopf U; Neuhaus P
    Transpl Int; 1996; 9 Suppl 1():S210-2. PubMed ID: 8959829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Famciclovir in chronic hepatitis B: results of a dose-finding study.
    Trépo C; Jezek P; Atkinson G; Boon R; Young C
    J Hepatol; 2000 Jun; 32(6):1011-8. PubMed ID: 10898322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.
    Tillmann HL; Trautwein C; Bock T; Böker KH; Jäckel E; Glowienka M; Oldhafer K; Bruns I; Gauthier J; Condreay LD; Raab HR; Manns MP
    Hepatology; 1999 Jul; 30(1):244-56. PubMed ID: 10385663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with lamivudine and famciclovir for chronic hepatitis B infection.
    Shen H; Alsatie M; Eckert G; Chalasani N; Lumeng L; Kwo PY
    Clin Gastroenterol Hepatol; 2004 Apr; 2(4):330-6. PubMed ID: 15067628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.